Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Pappa

Showing results (131-140 of 156) with videos related to

Pageof 16
Sort By:
Journal of Acquired Immune Deficiency Syndromes (1999)|November 1, 2006
Evolution of HIV resistance mutations in patients maintained on a stable treatment regimen after virologic failureMatthew Bidwell Goetz, Monique R Ferguson, Xueliang Han, et al.
Leukemia Research|April 14, 2012
Serum BAFF levels are related to angiogenesis and prognosis in patients with multiple myelomaM Fragioudaki, G Tsirakis, C A Pappa, et al.
HIV/AIDS (Auckland, N.Z.)|November 19, 2011
Impact of comorbidities and drug therapy on development of renal impairment in a predominantly African American and Hispanic HIV clinic populationM Keith Rawlings, Jennifer Klein, Edna P Toubes Klingler, et al.
Medical Oncology (Northwood, London, England)|January 30, 2015
Circulating serum levels of IL-20 in multiple myeloma patients: its significance in angiogenesis and disease activityM G Alexandrakis, C A Pappa, M Kokonozaki, et al.
Journal of Cancer Research and Clinical Oncology|March 17, 2015
Immunohistochemical expression of endoglin offers a reliable estimation of bone marrow neoangiogenesis in multiple myelomaMichael G Alexandrakis, Ioannis K Neonakis, Constantina A Pappa, et al.
Cytokine|September 24, 2011
Monitoring serum levels ELR+ CXC chemokines and the relationship between microvessel density and angiogenic growth factors in multiple myelomaC A Pappa, G Tsirakis, P Kanellou, et al.
International Journal of Immunopathology and Pharmacology|May 13, 2005
Serum evaluation of angiogenic cytokine basic fibroblast growth factor, hepatocyte growth factor and TNF-alpha in patients with myelodysplastic syndromes: correlation with bone marrow microvascular densityM G Alexandrakis, F H Passam, C A Pappa, et al.
Hematological Oncology|September 16, 2011
Role of platelet-derived growth factor-AB in tumour growth and angiogenesis in relation with other angiogenic cytokines in multiple myelomaGeorge Tsirakis, Constantina A Pappa, Peggy Kanellou, et al.
AIDS Research and Therapy|April 1, 2008
Fosamprenavir or atazanavir once daily boosted with ritonavir 100 mg, plus tenofovir/emtricitabine, for the initial treatment of HIV infection: 48-week results of ALERTKimberly Y Smith, Winkler G Weinberg, Edwin DeJesus, et al.
BMC Infectious Diseases|June 11, 2003
Twice-daily amprenavir 1200 mg versus amprenavir 600 mg/ritonavir 100 mg, in combination with at least 2 other antiretroviral drugs, in HIV-1-infected patientsJeffrey P Nadler, Joseph C Gathe, Richard B Pollard, et al.
Pageof 16

Showing results (131-140 of 156) with videos related to

Sort By:
Pageof 16
Journal of Acquired Immune Deficiency Syndromes (1999)|November 1, 2006
Evolution of HIV resistance mutations in patients maintained on a stable treatment regimen after virologic failureMatthew Bidwell Goetz, Monique R Ferguson, Xueliang Han, et al.
Leukemia Research|April 14, 2012
Serum BAFF levels are related to angiogenesis and prognosis in patients with multiple myelomaM Fragioudaki, G Tsirakis, C A Pappa, et al.
HIV/AIDS (Auckland, N.Z.)|November 19, 2011
Impact of comorbidities and drug therapy on development of renal impairment in a predominantly African American and Hispanic HIV clinic populationM Keith Rawlings, Jennifer Klein, Edna P Toubes Klingler, et al.
Medical Oncology (Northwood, London, England)|January 30, 2015
Circulating serum levels of IL-20 in multiple myeloma patients: its significance in angiogenesis and disease activityM G Alexandrakis, C A Pappa, M Kokonozaki, et al.
Journal of Cancer Research and Clinical Oncology|March 17, 2015
Immunohistochemical expression of endoglin offers a reliable estimation of bone marrow neoangiogenesis in multiple myelomaMichael G Alexandrakis, Ioannis K Neonakis, Constantina A Pappa, et al.
Cytokine|September 24, 2011
Monitoring serum levels ELR+ CXC chemokines and the relationship between microvessel density and angiogenic growth factors in multiple myelomaC A Pappa, G Tsirakis, P Kanellou, et al.
International Journal of Immunopathology and Pharmacology|May 13, 2005
Serum evaluation of angiogenic cytokine basic fibroblast growth factor, hepatocyte growth factor and TNF-alpha in patients with myelodysplastic syndromes: correlation with bone marrow microvascular densityM G Alexandrakis, F H Passam, C A Pappa, et al.
Hematological Oncology|September 16, 2011
Role of platelet-derived growth factor-AB in tumour growth and angiogenesis in relation with other angiogenic cytokines in multiple myelomaGeorge Tsirakis, Constantina A Pappa, Peggy Kanellou, et al.
AIDS Research and Therapy|April 1, 2008
Fosamprenavir or atazanavir once daily boosted with ritonavir 100 mg, plus tenofovir/emtricitabine, for the initial treatment of HIV infection: 48-week results of ALERTKimberly Y Smith, Winkler G Weinberg, Edwin DeJesus, et al.
BMC Infectious Diseases|June 11, 2003
Twice-daily amprenavir 1200 mg versus amprenavir 600 mg/ritonavir 100 mg, in combination with at least 2 other antiretroviral drugs, in HIV-1-infected patientsJeffrey P Nadler, Joseph C Gathe, Richard B Pollard, et al.
Pageof 16